Mind Medicine Inc
$ 7.30
3.25%
23 May - close price
- Market Cap 534,162,000 USD
- Current Price $ 7.30
- High / Low $ 7.37 / 6.72
- Stock P/E N/A
- Book Value 2.95
- EPS -0.75
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.26 %
- ROE -0.37 %
- 52 Week High 10.44
- 52 Week Low 4.70
About
Mind Medicine (MindMed) Inc., a psychedelic medicine biotechnology company, discovers, develops and deploys psychedelic-inspired medicines and therapies to address addiction and mental illness. The company is headquartered in New York, New York.
Analyst Target Price
$24.50
Quarterly Earnings
| Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-05-06 | 2025-02-26 | 2024-11-07 | 2024-08-13 | 2024-05-08 | 2024-02-28 | 2023-11-02 | 2023-08-03 | 2023-05-04 | 2023-03-09 | 2022-11-10 | 2022-08-11 |
| Reported EPS | -0.35 | -0.41 | -0.27 | -0.26 | -1.14 | -0.59 | -0.45 | -0.76 | -0.52 | -0.16 | -0.56 | -0.6 |
| Estimated EPS | -0.53 | -0.2786 | -0.28 | -0.33 | -0.53 | -0.46 | -0.67 | -0.54 | -0.42 | -0.5 | -0.6 | -0.75 |
| Surprise | 0.18 | -0.1314 | 0.01 | 0.07 | -0.61 | -0.13 | 0.22 | -0.22 | -0.1 | 0.34 | 0.04 | 0.15 |
| Surprise Percentage | 33.9623% | -47.1644% | 3.5714% | 21.2121% | -115.0943% | -28.2609% | 32.8358% | -40.7407% | -23.8095% | 68% | 6.6667% | 20% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MNMD
2025-05-20 21:33:45
Investors had a good mind to plow money into Mind Medicine ( NASDAQ: MNMD ) stock on Tuesday. Shares of the psychedelic-focused biotech, which also goes by the name of MindMed, provided a nice high by rising more than 8% in price on a legislative development.
2025-05-20 14:26:01
U.S. stocks were lower, with the Nasdaq Composite falling more than 50 points on Tuesday. Shares of Agilysys, Inc. AGYS rose sharply during Tuesday's session following better-than-expected fourth-quarter results.
2025-05-13 13:55:15
The mean of analysts' price targets for Mind Medicine MindMed (MNMD) points to a 279.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
2025-03-07 14:04:41
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wedbush raised Logitech International S.A. LOGI price target from $100 to $125.
2025-02-14 20:35:00
Mind Medicine ( NASDAQ: MNMD ) stock is seeing impressive gains Friday. The company's share price was up 16.9% as of 3:15 p.m. ET and had been up as much as 20.7% on the day earlier in the session.Mind Medicine's valuation is surging following Robert F.
2025-01-28 12:18:00
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
